Theravance Inc (NASDAQ:THRX)

17.13
Delayed Data
As of Apr 17
 -0.54 / -3.03%
Today’s Change
10.58
Today|||52-Week Range
31.80
+21.06%
Year-to-Date

Today’s Trading

Previous close17.67
Today’s open17.54
Day’s range16.93 - 17.69
Volume689,177
Average volume (3 months)944,771
Market cap$2.0B
Dividend yield5.84%
Data as of 3:59pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)+10.18%
Earnings growth (this year)+90.00%
Earnings growth (next 5 years)-167.64%
Revenue growth (last year)+309.82%
P/E ratioNM
Price/Sales81.32
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MNKDMannkind Corp-0.14-2.70%
MDCOMedicines Co-0.04-0.14%
IRWDIronwood Pharmaceuti...-0.52-3.34%
INSYINSYS Therapeutics I...-0.21-0.34%
Data as of 3:59pm ET, 04/17/2015

Financials

Next reporting dateApril 23, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$19.5M
Annual profit (last year)-$168.5M
Net profit margin-377.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Senior Vice President-
Operations
Frank C. Pasqualone
Corporate headquarters
South San Francisco, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers